KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Humana (HUM) EBITDA Margin (2016 - 2025)

Humana (HUM) has disclosed EBITDA Margin for 16 consecutive years, with 1.17% as the latest value for Q4 2025.

  • On a quarterly basis, EBITDA Margin changed N/A to 1.17% in Q4 2025 year-over-year; TTM through Dec 2025 was 1.54%, a N/A change, with the full-year FY2025 number at 2.68%, up 39086.0% from a year prior.
  • EBITDA Margin was 1.17% for Q4 2025 at Humana, up from 696.82% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 118.7% in Q3 2023 to a low of 696.82% in Q2 2025.
  • A 4-year average of 30.31% and a median of 6.22% in 2022 define the central range for EBITDA Margin.
  • Peak YoY movement for EBITDA Margin: tumbled -27589bps in 2021, then skyrocketed 11274bps in 2023.
  • Humana's EBITDA Margin stood at 1.31% in 2021, then tumbled by -139bps to 0.52% in 2022, then skyrocketed by 23116bps to 118.7% in 2023, then tumbled by -101bps to 1.17% in 2025.
  • Per Business Quant, the three most recent readings for HUM's EBITDA Margin are 1.17% (Q4 2025), 696.82% (Q2 2025), and 6.89% (Q1 2025).